Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLVer: HCL and Verapamil in New Onset T1D
NCT04233034Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jul 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of verapamil in type 1 diabetes mellitus (T1D), sponsored by Jaeb Center for Health Research. Started Jul 2020; status: completed.
02
Drugs
verapamil
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04233034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233034.